E-cigarette Usage Leads to Hospitalization: Disturbing Youth Trend

Regulations by 2FIRSTS.ai
Jan.03.2024
E-cigarette Usage Leads to Hospitalization: Disturbing Youth Trend
A teenager from Bogdanovci, Croatia was hospitalized after using an e-cigarette containing THC and HHC; public concern grows.

According to a report by Croatian media outlet Srednja.hr on January 2nd, a minor from Bogdanovci was hospitalized after using an e-cigarette containing tetrahydrocannabinol (THC) and hexahydrocannabinol (HHC).

 

Just ten days prior to this incident, a 15-year-old teenager collapsed in the school restroom after using an e-cigarette. The school janitor discovered the unconscious teenager and promptly alerted the authorities, who responded to the incident after receiving a report from the Woceval Hospital.

 

Currently, both incidents have sparked extreme public interest in the local community, with the police having now released the relevant details pertaining to these cases.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

InterTabac 2025 Insights|Altria Brings Two Nicotine Pouch Brands—On! and FUMi to InterTabac
InterTabac 2025 Insights|Altria Brings Two Nicotine Pouch Brands—On! and FUMi to InterTabac
2Firsts’ on-site reporting at InterTabac 2025 in Dortmund, Germany, found that Altria exhibited two nicotine pouch brands: On! and FUMi.
Sep.19 by 2FIRSTS.ai
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh has approved Philip Morris International to build a USD 5.82 million nicotine pouch factory in Narayanganj, the first of its kind in South Asia. Regulators called the project “completely legal” under national law, while anti-tobacco groups condemned the move, saying it violates a Supreme Court ban on approving new tobacco factories.
Nov.07 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
Malaysian Officials Issue Stern Warning Against Smuggling E-Cigarettes to Singapore, Highlighting Severe Consequences and Government Support for Nationwide Ban.
Malaysian Officials Issue Stern Warning Against Smuggling E-Cigarettes to Singapore, Highlighting Severe Consequences and Government Support for Nationwide Ban.
Johor official warns Malaysians against smuggling e-cigarettes into Singapore; strict penalties await violators. Support for nationwide ban grows.
Sep.15 by 2FIRSTS.ai
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.
Oct.15 by 2FIRSTS.ai